Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Estates Ltd Wilmslow currently holds 5,258,859 shares of HISTOGENICS CORP (HSGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Estates Ltd Wilmslow has been a net buyer of HSGX stock. They have purchased $4.3M and sold $8.7K worth of shares.
Estates Ltd Wilmslow's most recent insider trade was on Feb 8, 2019, when they sold 1,244,444 shares at $0.00 per share.
Estates Ltd Wilmslow serves as Executive at HISTOGENICS CORP (HSGX). They have executed 12 insider transactions totaling $4.4M over their tenure at the company.
Estates Ltd Wilmslow holds the position of Executive at HISTOGENICS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Estates Ltd Wilmslow has shown a buying trading pattern, with $4.3M in total purchases and $8.7K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Estates Ltd Wilmslow was on Dec 8, 2014, when they purchased $4.3M worth of HSGX shares. This transaction involved 394,918 shares at $11.00 per share.
Estates Ltd Wilmslow currently owns 5,258,859 shares of HISTOGENICS CORP (HSGX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Estates Ltd Wilmslow's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Estates Ltd Wilmslow has 12 Form 4 filings on record as an insider at HISTOGENICS CORP.
Set alerts for Estates Ltd Wilmslow and 40,000+ other insiders.